{"id":"W7116981447","doi":"10.1016/j.annonc.2025.10.609","title":"903MO Neoadjuvant (neoadj) osimertinib (osi) ± chemotherapy (CT) vs CT alone in patients (pts) with resectable epidermal growth factor receptor-mutated (EGFRm) stage II–IIIB non-small cell lung cancer (NSCLC): Patient-reported outcomes (PROs) from NeoADAURA","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Osimertinib; Lung cancer; Chemotherapy; Neoadjuvant therapy; Stage (stratigraphy); Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004036472,0.0003008222,0.000524141,0.0001207867,0.0001028938,0.000382056,0.0001758274,0.0002667468,0.001511009],"category_scores_gemma":[0.0003794316,0.0001050144,0.000816617,0.0001642829,0.0002578638,0.0004204097,0.0002361259,0.0007550757,0.0001983466],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003634953,"about_ca_system_score_gemma":0.000423316,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005911819,"about_ca_topic_score_gemma":0.002501064,"domain_scores_codex":[0.9998668,0.00004383902,0.000009260285,0.00002853079,0.00001237834,0.00003904459],"domain_scores_gemma":[0.9998081,0.00004597202,0.00004867482,0.00001075919,0.0000058954,0.00008068587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7014951,0.007418317,0.1005185,0.0005965175,0.001777037,0.0002616893,0.0001907834,0.003395278,0.01336451,0.0005961118,0.002726245,0.16766],"study_design_scores_gemma":[0.05910766,0.433035,0.4832845,0.0002870125,0.004229012,0.0009161218,0.0005531483,0.004695599,0.005975508,0.001127072,0.006715367,0.00007393048],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975943,0.0009703294,0.00004737421,0.000114608,0.00005623869,0.00002641073,0.0001716473,0.000006398478,0.001012669],"genre_scores_gemma":[0.998427,0.0005516109,0.00007000066,0.0001349885,0.0000499387,0.00002886586,0.0003417069,0.000001704461,0.0003940428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001511009,"threshold_uncertainty_score":0.005054832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02185888554162075,"score_gpt":0.3492037609387038,"score_spread":0.327344875397083,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}